Heron Therapeutics, Inc. (HRTX)
USD 1.87
(-10.95%)
USD 1.87
(-10.95%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 127.04 Million USD | 17.99% |
| 2022 | 107.67 Million USD | 24.7% |
| 2021 | 86.34 Million USD | -2.59% |
| 2020 | 88.63 Million USD | -39.28% |
| 2019 | 145.96 Million USD | 88.41% |
| 2018 | 77.47 Million USD | 151.81% |
| 2017 | 30.76 Million USD | 2305.55% |
| 2016 | 1.27 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 646 Thousand USD | -50.35% |
| 2010 | 1.3 Million USD | 3.17% |
| 2009 | 1.26 Million USD | 241.73% |
| 2008 | 369 Thousand USD | -10.44% |
| 2007 | 412 Thousand USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 5.39 Million USD | -0.24% |
| 2004 | 5.4 Million USD | 11.47% |
| 2003 | 4.84 Million USD | -16.63% |
| 2002 | 5.81 Million USD | 32.54% |
| 2001 | 4.38 Million USD | 30.35% |
| 2000 | 3.36 Million USD | -83.5% |
| 1999 | 20.4 Million USD | 2.0% |
| 1998 | 20 Million USD | 9.29% |
| 1997 | 18.3 Million USD | -2.14% |
| 1996 | 18.7 Million USD | 16.15% |
| 1995 | 16.1 Million USD | 1.26% |
| 1994 | 15.9 Million USD | -20.1% |
| 1993 | 19.9 Million USD | 172.6% |
| 1992 | 7.3 Million USD | 160.71% |
| 1991 | 2.8 Million USD | 16.67% |
| 1990 | 2.4 Million USD | -14.29% |
| 1989 | 2.8 Million USD | 12.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 34.67 Million USD | 1.28% |
| 2024 Q2 | 36.02 Million USD | 3.91% |
| 2023 Q3 | 31.43 Million USD | -1.03% |
| 2023 Q4 | 34.23 Million USD | 8.9% |
| 2023 Q2 | 31.76 Million USD | 7.25% |
| 2023 FY | 127.04 Million USD | 17.99% |
| 2023 Q1 | 29.61 Million USD | -1.38% |
| 2022 FY | 107.67 Million USD | 24.7% |
| 2022 Q1 | 23.45 Million USD | 13.57% |
| 2022 Q2 | 27.63 Million USD | 17.79% |
| 2022 Q3 | 26.55 Million USD | -3.88% |
| 2022 Q4 | 30.02 Million USD | 13.07% |
| 2021 Q2 | 22.44 Million USD | 12.11% |
| 2021 Q1 | 20.01 Million USD | -2.85% |
| 2021 Q3 | 23.23 Million USD | 3.51% |
| 2021 Q4 | 20.65 Million USD | -11.08% |
| 2021 FY | 86.34 Million USD | -2.59% |
| 2020 Q4 | 20.6 Million USD | 3.21% |
| 2020 Q3 | 19.96 Million USD | -11.92% |
| 2020 FY | 88.63 Million USD | -39.28% |
| 2020 Q1 | 25.4 Million USD | -27.6% |
| 2020 Q2 | 22.66 Million USD | -10.76% |
| 2019 Q3 | 42.62 Million USD | 16.27% |
| 2019 Q2 | 36.65 Million USD | 16.0% |
| 2019 Q1 | 31.6 Million USD | 9.56% |
| 2019 FY | 145.96 Million USD | 88.41% |
| 2019 Q4 | 35.08 Million USD | -17.69% |
| 2018 Q4 | 28.84 Million USD | 45.78% |
| 2018 Q2 | 17.27 Million USD | 49.36% |
| 2018 FY | 77.47 Million USD | 151.81% |
| 2018 Q1 | 11.56 Million USD | 15.06% |
| 2018 Q3 | 19.78 Million USD | 14.52% |
| 2017 Q4 | 10.05 Million USD | 17.28% |
| 2017 Q1 | 3.63 Million USD | 183.97% |
| 2017 Q2 | 8.51 Million USD | 134.31% |
| 2017 FY | 30.76 Million USD | 2305.55% |
| 2017 Q3 | 8.57 Million USD | 0.73% |
| 2016 Q3 | 661 Thousand USD | 0.0% |
| 2016 FY | 1.27 Million USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | 1.27 Million USD | 93.49% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q1 | 395 Thousand USD | 120.67% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | 251 Thousand USD | -36.46% |
| 2011 Q3 | - USD | -100.0% |
| 2011 FY | 646 Thousand USD | -50.35% |
| 2010 Q1 | 241 Thousand USD | 97.54% |
| 2010 Q2 | 530 Thousand USD | 119.92% |
| 2010 Q3 | 351 Thousand USD | -33.77% |
| 2010 Q4 | 179 Thousand USD | -49.0% |
| 2010 FY | 1.3 Million USD | 3.17% |
| 2009 Q1 | 8000.00 USD | -61.9% |
| 2009 Q3 | 1.11 Million USD | 7878.57% |
| 2009 Q4 | 122 Thousand USD | -89.08% |
| 2009 FY | 1.26 Million USD | 241.73% |
| 2009 Q2 | 14 Thousand USD | 75.0% |
| 2008 Q4 | 21 Thousand USD | -67.19% |
| 2008 Q1 | 133 Thousand USD | 0.76% |
| 2008 Q2 | 152 Thousand USD | 14.29% |
| 2008 FY | 369 Thousand USD | -10.44% |
| 2008 Q3 | 64 Thousand USD | -57.89% |
| 2007 Q2 | 160 Thousand USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | 121 Thousand USD | -24.38% |
| 2007 FY | 412 Thousand USD | 0.0% |
| 2007 Q4 | 132 Thousand USD | 9.09% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q2 | 1.25 Million USD | -8.09% |
| 2005 Q4 | 1.44 Million USD | 8.0% |
| 2005 Q3 | 1.33 Million USD | 6.96% |
| 2005 FY | 5.39 Million USD | -0.24% |
| 2005 Q1 | 1.36 Million USD | -8.23% |
| 2004 FY | 5.4 Million USD | 11.47% |
| 2004 Q1 | 1.18 Million USD | -13.11% |
| 2004 Q4 | 1.48 Million USD | 1.65% |
| 2004 Q3 | 1.45 Million USD | 13.55% |
| 2004 Q2 | 1.28 Million USD | 8.81% |
| 2003 FY | 4.84 Million USD | -16.63% |
| 2003 Q3 | 1.26 Million USD | 13.52% |
| 2003 Q4 | 1.35 Million USD | 7.1% |
| 2003 Q2 | 1.11 Million USD | 0.99% |
| 2003 Q1 | 1.1 Million USD | -44.31% |
| 2002 Q3 | 1.34 Million USD | 7.53% |
| 2002 FY | 5.81 Million USD | 32.54% |
| 2002 Q4 | 1.98 Million USD | 47.88% |
| 2002 Q1 | 1.23 Million USD | -14.51% |
| 2002 Q2 | 1.24 Million USD | 0.92% |
| 2001 Q4 | 1.44 Million USD | 49.46% |
| 2001 FY | 4.38 Million USD | 30.35% |
| 2001 Q1 | 970.73 Thousand USD | 10.31% |
| 2001 Q2 | 1 Million USD | 3.04% |
| 2001 Q3 | 968.62 Thousand USD | -3.16% |
| 2000 FY | 3.36 Million USD | -83.5% |
| 2000 Q3 | 886.56 Thousand USD | 2.02% |
| 2000 Q2 | 869.03 Thousand USD | -81.29% |
| 2000 Q4 | 880.01 Thousand USD | -0.74% |
| 2000 Q1 | 4.64 Million USD | -56.58% |
| 1999 Q1 | 4.6 Million USD | -11.54% |
| 1999 FY | 20.4 Million USD | 2.0% |
| 1999 Q3 | 4.9 Million USD | 4.26% |
| 1999 Q2 | 4.7 Million USD | 2.17% |
| 1999 Q4 | 10.7 Million USD | 118.37% |
| 1998 Q1 | 4.6 Million USD | 0.0% |
| 1998 FY | 20 Million USD | 9.29% |
| 1998 Q2 | 5.1 Million USD | 10.87% |
| 1998 Q4 | 5.2 Million USD | 0.0% |
| 1998 Q3 | 5.2 Million USD | 1.96% |
| 1997 FY | 18.3 Million USD | -2.14% |
| 1997 Q2 | 4.5 Million USD | -10.0% |
| 1997 Q4 | 4.6 Million USD | 12.2% |
| 1997 Q3 | 4.1 Million USD | -8.89% |
| 1997 Q1 | 5 Million USD | 31.58% |
| 1996 FY | 18.7 Million USD | 16.15% |
| 1996 Q1 | 5.2 Million USD | 62.5% |
| 1996 Q3 | 4.4 Million USD | -18.52% |
| 1996 Q2 | 5.4 Million USD | 3.85% |
| 1996 Q4 | 3.8 Million USD | -13.64% |
| 1995 Q2 | 4.7 Million USD | -7.84% |
| 1995 Q4 | 3.2 Million USD | 3.23% |
| 1995 Q3 | 3.1 Million USD | -34.04% |
| 1995 FY | 16.1 Million USD | 1.26% |
| 1995 Q1 | 5.1 Million USD | 70.0% |
| 1994 Q2 | 4.4 Million USD | -13.73% |
| 1994 Q1 | 5.1 Million USD | 6.25% |
| 1994 FY | 15.9 Million USD | -20.1% |
| 1994 Q3 | 3.4 Million USD | -22.73% |
| 1994 Q4 | 3 Million USD | -11.76% |
| 1993 Q3 | 4.1 Million USD | -19.61% |
| 1993 FY | 19.9 Million USD | 172.6% |
| 1993 Q4 | 4.8 Million USD | 17.07% |
| 1993 Q1 | 2.5 Million USD | 4.17% |
| 1993 Q2 | 5.1 Million USD | 104.0% |
| 1992 Q1 | 700 Thousand USD | 75.0% |
| 1992 FY | 7.3 Million USD | 160.71% |
| 1992 Q3 | 2 Million USD | -9.09% |
| 1992 Q4 | 2.4 Million USD | 20.0% |
| 1992 Q2 | 2.2 Million USD | 214.29% |
| 1991 FY | 2.8 Million USD | 16.67% |
| 1991 Q4 | 400 Thousand USD | -20.0% |
| 1991 Q1 | 400 Thousand USD | -42.86% |
| 1991 Q2 | 1.5 Million USD | 275.0% |
| 1991 Q3 | 500 Thousand USD | -66.67% |
| 1990 FY | 2.4 Million USD | -14.29% |
| 1990 Q1 | 600 Thousand USD | 0.0% |
| 1990 Q3 | 400 Thousand USD | -50.0% |
| 1990 Q4 | 700 Thousand USD | 75.0% |
| 1990 Q2 | 800 Thousand USD | 33.33% |
| 1989 Q1 | 500 Thousand USD | 0.0% |
| 1989 Q3 | 500 Thousand USD | -61.54% |
| 1989 Q4 | 600 Thousand USD | 20.0% |
| 1989 FY | 2.8 Million USD | 12.0% |
| 1989 Q2 | 1.3 Million USD | 160.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -234.107% |
| Alkermes plc | 1.66 Billion USD | 92.362% |
| Agenus Inc. | 156.31 Million USD | 18.725% |
| Aptorum Group Limited | 431.37 Thousand USD | -29350.737% |
| Ardelyx, Inc. | 124.45 Million USD | -2.079% |
| Dyadic International, Inc. | 2.89 Million USD | -4282.632% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -301.504% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -48669.29% |
| Novavax, Inc. | 983.7 Million USD | 87.085% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -1471.743% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -566.933% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -1178.623% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -15740.898% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | 22.494% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -1444.42% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -512.083% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 93.051% |
| AlloVir, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 47.227% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -29863.208% |
| Bicycle Therapeutics plc | 26.97 Million USD | -370.952% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -9106.087% |
| ChromaDex Corporation | 83.57 Million USD | -52.021% |
| Chimerix, Inc. | 324 Thousand USD | -39111.111% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -268.489% |
| CRISPR Therapeutics AG | 371.2 Million USD | 65.775% |
| Precision BioSciences, Inc. | 48.72 Million USD | -160.726% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -99.965% |
| Fortress Biotech, Inc. | 84.51 Million USD | -50.325% |
| Fortress Biotech, Inc. | 84.51 Million USD | -50.325% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -531.149% |
| ImmuCell Corporation | 17.47 Million USD | -627.143% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -443.271% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 96.562% |
| Innoviva, Inc. | 310.46 Million USD | 59.079% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 9.76 Million USD | -1201.547% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -84035.099% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | 3.252% |
| ContextLogic Inc. | 287 Million USD | 55.734% |
| MiMedx Group, Inc. | 321.47 Million USD | 60.481% |
| MEI Pharma, Inc. | 65.29 Million USD | -94.563% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -217199.239% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -16083.949% |
| Opthea Limited | 261.85 Thousand USD | -48416.186% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -1940.867% |
| Pharming Group N.V. | 245.31 Million USD | 48.212% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -18528.152% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -196.762% |
| PureTech Health plc | 3.33 Million USD | -3715.135% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -8.694% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -1228.912% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | 27.911% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -8075.29% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -4860.718% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -1346.97% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -2540780.0% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | 1.526% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -11840.226% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -12.126% |
| Seer, Inc. | 15.18 Million USD | -736.807% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -2379.391% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -421.656% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -1270340.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -6958.0% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | 34.723% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | 68.096% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -4503.043% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -102.174% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -954.745% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -15035.836% |
| Century Therapeutics, Inc. | 2.23 Million USD | -5584.295% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -503.563% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -25.52% |
| Autolus Therapeutics plc | 1.69 Million USD | -7381.979% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -176.075% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -186729.412% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | 25.389% |
| GRI Bio, Inc. | 21.76 Million USD | -483.654% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -4901.76% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -5864.507% |
| INmune Bio, Inc. | 155 Thousand USD | -81863.871% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -5574.163% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -12604.4% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -1381.908% |
| Coherus BioSciences, Inc. | 257.24 Million USD | 50.613% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -3529.829% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -7940.759% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -1535.479% |
| Histogen Inc. | 3.76 Million USD | -3270.761% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -21682.793% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -116454.128% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -32334.42% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -274.993% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -1753.845% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | 19.464% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -87035.802% |
| Apollomics, Inc. | 821 Thousand USD | -15374.3% |
| Amarin Corporation plc | 306.91 Million USD | 58.606% |
| Mesoblast Limited | 5.9 Million USD | -2052.558% |
| Turnstone Biologics Corp. | 19.3 Million USD | -558.054% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -61.65% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | 27.616% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 93.058% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -65.02% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | 67.966% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -9445.004% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | 9.197% |
| Insmed Incorporated | 305.2 Million USD | 58.375% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -579.889% |
| OmniAb, Inc. | 34.16 Million USD | -271.865% |
| Alector, Inc. | 97.06 Million USD | -30.89% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -0.569% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -123243.689% |
| Zai Lab Limited | 266.71 Million USD | 52.368% |
| Revance Therapeutics, Inc. | 234.04 Million USD | 45.717% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -97626.154% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -628.171% |
| Veracyte, Inc. | 361.05 Million USD | 64.813% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -2663.19% |
| FibroGen, Inc. | 147.75 Million USD | 14.015% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -85853.79% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 96.687% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -30148.571% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | 66.636% |
| TG Therapeutics, Inc. | 233.66 Million USD | 45.629% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 95.914% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -8054.3% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -271.963% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -49.782% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -121.239% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | 70.744% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -183.859% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | 61.666% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -230135.593% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -388.556% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -1411500.0% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -3736.874% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 99.031% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -103938.915% |
| Pluri Inc. | 326 Thousand USD | -38870.552% |
| Prothena Corporation plc | 91.37 Million USD | -39.043% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -110.753% |
| Celularity Inc. | 22.77 Million USD | -457.92% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -2214.098% |
| MeiraGTx Holdings plc | 14.01 Million USD | -806.357% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | 49.066% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -98.801% |
| Blueprint Medicines Corporation | 249.38 Million USD | 49.056% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -309.965% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -1640.806% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -250.225% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -2443.091% |
| Cytokinetics, Incorporated | 7.53 Million USD | -1587.171% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -5992.32% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -1.802% |
| Evogene Ltd. | 5.64 Million USD | -2152.553% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -1171.33% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -1265.624% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -2546.75% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -247.808% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -40359.873% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -6252.2% |
| MediciNova, Inc. | 1 Million USD | -12604.4% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -5091.827% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -744371.14% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | 53.051% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | 86.453% |
| Mereo BioPharma Group plc | 10 Million USD | -1170.44% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -2121.826% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -513.058% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | 52.992% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -4429.198% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | 73.663% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -133630.526% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -2570.113% |
| Kezar Life Sciences, Inc. | 7 Million USD | -1714.914% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -505.895% |
| aTyr Pharma, Inc. | 353 Thousand USD | -35889.802% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -718.108% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -40359.873% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -1053420.192% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | 84.68% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -56062.47% |
| UroGen Pharma Ltd. | 82.71 Million USD | -53.596% |
| Sutro Biopharma, Inc. | 153.73 Million USD | 17.36% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -459371.971% |
| Orgenesis Inc. | 530 Thousand USD | -23870.566% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | 24.53% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -50001.549% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | 34.051% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -56062.47% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -744371.14% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -8352.695% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -2340.922% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -1059.266% |
| scPharmaceuticals Inc. | 13.59 Million USD | -834.628% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -1167.525% |
| Daré Bioscience, Inc. | 2.8 Million USD | -4424.544% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -68945.652% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 94.833% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -997.098% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -111.74% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -330.701% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 94.749% |
| DBV Technologies S.A. | 15.72 Million USD | -707.757% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 98.145% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1486.86% |
| Molecular Templates, Inc. | 57.3 Million USD | -121.694% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | 12.527% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -1159.233% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -1745.765% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -116.249% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -19591.371% |
| Adagene Inc. | 18.11 Million USD | -601.455% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -11641.59% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | 56.032% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | 49.184% |
| SciSparc Ltd. | 2.87 Million USD | -4312.782% |
| Vericel Corporation | 197.51 Million USD | 35.679% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -2051.829% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -113.14% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -397.315% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -31.332% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -26.554% |
| ADMA Biologics, Inc. | 258.21 Million USD | 50.799% |
| Clene Inc. | 654 Thousand USD | -19325.688% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -404.582% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -185.012% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -154.088% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -118632.71% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -47.417% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -173666.276% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -117.381% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -980.49% |
| Trevena, Inc. | 3.12 Million USD | -3965.408% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | 82.511% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -1920.42% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -1513.052% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -20325.08% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -2234.509% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -81.121% |
| Celularity Inc. | 22.77 Million USD | -457.92% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3065.811% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -81120.312% |
| Cibus, Inc. | 1.81 Million USD | -6891.965% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -3429.0% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -1673.614% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -6503.119% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | 83.87% |
| Eyenovia, Inc. | 3787.00 USD | -3354639.9% |
| Puma Biotechnology, Inc. | 235.63 Million USD | 46.085% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -15.161% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -25933.607% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -60.401% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -13937.251% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -53505.063% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -1776.85% |
| Royalty Pharma plc | 2.35 Billion USD | 94.604% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -17211.489% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -244.713% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -74631.765% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -10451.827% |
| Notable Labs, Ltd. | 310 Thousand USD | -40881.935% |
| Liquidia Corporation | 17.48 Million USD | -626.464% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -11641.59% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -600.314% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -6722.986% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -7318.216% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 94.542% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -176100.383% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -2570.113% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -423380.0% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -701.894% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -96.349% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -29722.535% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | 68.188% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -279.701% |
| Peak Bio, Inc. | 367.87 Thousand USD | -34434.369% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -362.634% |
| Benitec Biopharma Inc. | 216 Thousand USD | -58716.667% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -14239.052% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 89.64% |
| Immunome, Inc. | 14.01 Million USD | -806.292% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -7567.109% |
| CervoMed Inc. | 7.14 Million USD | -1678.114% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -2485.874% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -4395.541% |
| Moolec Science SA | 905.04 Thousand USD | -13937.251% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -15169.528% |
| AnaptysBio, Inc. | 17.15 Million USD | -640.479% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -5064.287% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -5666.863% |
| Lumos Pharma, Inc. | 2.05 Million USD | -6094.247% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -211.954% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -5992.32% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -62176.471% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -105770.0% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -50717.6% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | 66.365% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | 31.834% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -217.61% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -10584.945% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -722.238% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -22188.421% |
| HCW Biologics Inc. | 2.84 Million USD | -4370.556% |
| XOMA Corporation | 4.75 Million USD | -2570.113% |
| Nektar Therapeutics | 90.12 Million USD | -40.969% |
| Arvinas, Inc. | 78.5 Million USD | -61.839% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -189.085% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -4006.141% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -19325.688% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -7155.511% |
| Synlogic, Inc. | 3.37 Million USD | -3668.733% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -34434.369% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -537.036% |
| Krystal Biotech, Inc. | 50.69 Million USD | -150.585% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | 13.003% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -2232.366% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -28156.049% |
| MannKind Corporation | 198.96 Million USD | 36.147% |
| Ikena Oncology, Inc. | 9.16 Million USD | -1286.943% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -11.982% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | 55.446% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -3176000.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -153.303% |
| REGENXBIO Inc. | 90.24 Million USD | -40.781% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -5595.712% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -1621.697% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -16727.02% |
| Longeveron Inc. | 709 Thousand USD | -17818.759% |
| Repare Therapeutics Inc. | 51.13 Million USD | -148.458% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | 89.782% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -997.098% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -60397.143% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 98.713% |
| Denali Therapeutics Inc. | 330.53 Million USD | 61.564% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -679.557% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -4600.111% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -64.08% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -83245.798% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -751.558% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -18721.333% |
| OmniAb, Inc. | 34.16 Million USD | -271.865% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -497.798% |
| Lipocine Inc. | -2.85 Million USD | 4556.405% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -5574.163% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -53.972% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -46.948% |
| Ocugen, Inc. | 6.03 Million USD | -2004.771% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -10889.965% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -252.078% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -2016.622% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -19966.909% |
| Dominari Holdings Inc. | 2.03 Million USD | -6130.701% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | 89.039% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -373.638% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | 78.172% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -908.686% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -26533.962% |
| Iterum Therapeutics plc | - USD | -Infinity% |